Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry R Davis

Showing results (1-10 of 185) with videos related to

Pageof 19
Sort By:
Diabetes Care|December 20, 2023
Aspirin Dosing in Cardiovascular Disease and Diabetes: Insights From ADAPTABLEDavid Aguilar, Barry R Davis
The New England Journal of Medicine|March 14, 2009
Benazepril plus amlodipine or hydrochlorothiazide for hypertensionBarry R Davis, Paul K Whelton,
Progress in Cardiovascular Diseases|January 10, 2012
Secondary analyses in cardiovascular clinical trials - statistical and other considerations. IntroductionBarbara C Tilley, Barry R Davis
The Journal of Infectious Diseases|September 14, 2010
Has oseltamivir been shown to be effective for treatment of H5N1 influenza?Robert B Couch, Barry R Davis
Circulation|May 21, 2008
Thiazide-type diuretics and beta-adrenergic blockers as first-line drug treatments for hypertensionJeffrey A Cutler, Barry R Davis
The American Surgeon|July 5, 2015
Analysis of Patients Undergoing Coronary Artery Bypass Grafting Who Have Already Had Prior Percutaneous Coronary InterventionGautam Bhatia, Barry R Davis, Christopher C Wright
Journal of Biopharmaceutical Statistics|May 6, 2003
Analysis of survival data with missing measurements of a time-dependent binary covariateSusan Halabi, Chuan-Chuan Wun, Barry R Davis
Journal of Applied Statistics|May 15, 2018
Bayesian regression model for recurrent event data with event-varying covariate effects and event effectLi-An Lin, Sheng Luo, Barry R Davis
American Journal of Epidemiology|December 22, 2022
A Dynamic Risk Model for Multitype Recurrent EventsAlokananda Ghosh, Wenyaw Chan, Naji Younes, et al.
The New England Journal of Medicine|July 9, 2003
Angiotensin-converting-enzyme inhibitors and diuretics for hypertensionBarry R Davis, Jackson T Wright, Jeffrey A Cutler
Pageof 19

Showing results (1-10 of 185) with videos related to

Sort By:
Pageof 19
Diabetes Care|December 20, 2023
Aspirin Dosing in Cardiovascular Disease and Diabetes: Insights From ADAPTABLEDavid Aguilar, Barry R Davis
The New England Journal of Medicine|March 14, 2009
Benazepril plus amlodipine or hydrochlorothiazide for hypertensionBarry R Davis, Paul K Whelton,
Progress in Cardiovascular Diseases|January 10, 2012
Secondary analyses in cardiovascular clinical trials - statistical and other considerations. IntroductionBarbara C Tilley, Barry R Davis
The Journal of Infectious Diseases|September 14, 2010
Has oseltamivir been shown to be effective for treatment of H5N1 influenza?Robert B Couch, Barry R Davis
Circulation|May 21, 2008
Thiazide-type diuretics and beta-adrenergic blockers as first-line drug treatments for hypertensionJeffrey A Cutler, Barry R Davis
The American Surgeon|July 5, 2015
Analysis of Patients Undergoing Coronary Artery Bypass Grafting Who Have Already Had Prior Percutaneous Coronary InterventionGautam Bhatia, Barry R Davis, Christopher C Wright
Journal of Biopharmaceutical Statistics|May 6, 2003
Analysis of survival data with missing measurements of a time-dependent binary covariateSusan Halabi, Chuan-Chuan Wun, Barry R Davis
Journal of Applied Statistics|May 15, 2018
Bayesian regression model for recurrent event data with event-varying covariate effects and event effectLi-An Lin, Sheng Luo, Barry R Davis
American Journal of Epidemiology|December 22, 2022
A Dynamic Risk Model for Multitype Recurrent EventsAlokananda Ghosh, Wenyaw Chan, Naji Younes, et al.
The New England Journal of Medicine|July 9, 2003
Angiotensin-converting-enzyme inhibitors and diuretics for hypertensionBarry R Davis, Jackson T Wright, Jeffrey A Cutler
Pageof 19